Post-approval studies (Phase 4)WithdrawnNCT02400775
What this trial is testing
Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.
Who this might be right for
Essential Hypertension With Stable Angina and Dyslipidemia
Takeda